In the Horizon Europe (HE) program, the European Commission (EC) is placing a strong focus on prediction and prevention, with the aim to treat diseases before they even develop and ensure a healthy society reaching old age. Cancer is a major burden to society worldwide, with millions of people being diagnosed each year. 

In many countries, cancer ranks the second most common cause of death following cardiovascular diseases. Cancer is best treated when detected as early as possible, before the development of symptoms. This is a difficult task, since markers of future disease have to be identified. 

The call “Accessible and affordable tests to advance early detection of heritable cancers in European regions” from the Mission Cancer aims to advance the detection of cancer before its onset, by identifying potential targets (biomarkers, genetic and epigenetic markers, use of family history and large data sets) and developing cancer tests for early diagnosis that are easy to use and affordable. 

A special focus is placed on the prediction of cancer in children, adolescents and young adults, since these groups of society have to live longest with the consequences of aggressive cancer treatments. If you are planning to submit a proposal, the MIC can support you with your application!